Three-Day diet before surgery may cut wound complications in sarcoma patients
NCT ID NCT02792270
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether eating a very low-calorie diet for three days before surgery can reduce wound complications in people with soft tissue sarcoma of the leg. Participants will drink special nutritional supplements instead of regular food. The goal is to see if this short-term diet improves physical function and wound healing after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- caloric restriction diet (Ensure and Boost supplements)
- What this could lead to
- If it works, this could point toward a simple dietary change before surgery to help sarcoma patients heal faster and avoid wound problems.
- What could go wrong
- This is a very small early study with only 32 participants, so results may not apply to everyone. The diet is short-term and low in protein, which might not suit all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts general Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can engineered immune cells tackle childhood sarcoma?
- Can a Patient's own immune cells be engineered to fight a rare sarcoma?
- Can a Patient's own immune cells fight advanced sarcoma?
- Could a massive tissue bank unlock sarcoma's secrets?
- Can a new protein drug shield kids with cancer from dangerous infections?
- Can two drugs together fight Hard-to-Treat bone and Soft-Tissue cancers?